Organogenesis Holdings Inc.
ORGO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $482,043 | $433,140 | $450,893 | $467,359 |
| % Growth | 11.3% | -3.9% | -3.5% | – |
| Cost of Goods Sold | $115,741 | $106,481 | $105,019 | $114,199 |
| Gross Profit | $366,302 | $326,659 | $345,874 | $353,160 |
| % Margin | 76% | 75.4% | 76.7% | 75.6% |
| R&D Expenses | $50,271 | $44,380 | $39,762 | $30,742 |
| G&A Expenses | $0 | $264,529 | $278,996 | $0 |
| SG&A Expenses | $294,513 | $269,754 | $283,808 | $250,200 |
| Sales & Mktg Exp. | $0 | $5,225 | $4,812 | $0 |
| Other Operating Expenses | $22,801 | $0 | $0 | $0 |
| Operating Expenses | $367,585 | $314,134 | $323,570 | $280,942 |
| Operating Income | -$1,283 | $12,525 | $22,304 | $72,218 |
| % Margin | -0.3% | 2.9% | 4.9% | 15.5% |
| Other Income/Exp. Net | -$1,524 | -$2,133 | -$2,022 | -$9,132 |
| Pre-Tax Income | -$2,807 | $10,392 | $20,282 | $63,086 |
| Tax Expense | -$3,668 | $5,447 | $4,750 | -$31,116 |
| Net Income | $861 | $4,945 | $15,532 | $94,202 |
| % Margin | 0.2% | 1.1% | 3.4% | 20.2% |
| EPS | 0.007 | 0.038 | 0.12 | 0.73 |
| % Growth | -82.8% | -68.6% | -83.6% | – |
| EPS Diluted | 0.007 | 0.037 | 0.12 | 0.7 |
| Weighted Avg Shares Out | 131,673 | 131,231 | 130,070 | 128,331 |
| Weighted Avg Shares Out Dil | 131,673 | 132,747 | 132,383 | 133,663 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,544 | $2,190 | $2,009 | $7,236 |
| Depreciation & Amortization | $17,026 | $23,449 | $18,031 | $16,676 |
| EBITDA | $15,763 | $36,031 | $40,322 | $86,998 |
| % Margin | 3.3% | 8.3% | 8.9% | 18.6% |